StockTipsArenaBeta

BUY Abbott India Limited — Ansh Jogendra Bhilwar

BUYAbbott India Limited
Abbott India share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: NA (inferred 1–3 months)13 Aug 2026via Zee Business (Live)

Entry₹28,610Inferred
Target₹30,950
Total upside +8.18% (call closed)
Stop loss₹26,730-6.57% risk
Exit₹26,73017 Aug 2026, 12:08 pm
Stop-loss hit-6.57%
Follow Ansh Jogendra Bhilwar for new callsGet alertsWatch ABBOTINDIA for new buy/sell callsGet alertsSee 85 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Aug 2026
1 supporting2 neutral1 opposing
Supports the BUY call (1)

3 advisors have active long-term BUY calls on this stock

Advisor consensus · adjacent horizon·13 May · 3mo ago

Neutral / worth noting (2)

Abbott India Q1 net profit surges 17% despite 4% revenue growth

NewsCnbc-Tv18·12 Aug · 4d ago

(opens in new tab)

Hero MotoCorp, Abbott India, Bharti Airtel, Data Patterns, Divis Labs Dividend Record Date: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·23 Jul · 4w ago

(opens in new tab)
Weighs against the BUY call (1)

Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%

NewsLivemint·24 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Abbott India

All analyst calls on Abbott India

More from Ansh Jogendra Bhilwar

Every call and its outcome